263 related articles for article (PubMed ID: 24236201)
1. Platelet P2Y12 is involved in murine pulmonary metastasis.
Wang Y; Sun Y; Li D; Zhang L; Wang K; Zuo Y; Gartner TK; Liu J
PLoS One; 2013; 8(11):e80780. PubMed ID: 24236201
[TBL] [Abstract][Full Text] [Related]
2. P2Y12 Receptor Modulates Sepsis-Induced Inflammation.
Liverani E; Rico MC; Tsygankov AY; Kilpatrick LE; Kunapuli SP
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):961-71. PubMed ID: 27055904
[TBL] [Abstract][Full Text] [Related]
3. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
Gebremeskel S; LeVatte T; Liwski RS; Johnston B; Bezuhly M
Int J Cancer; 2015 Jan; 136(1):234-40. PubMed ID: 24798403
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
[TBL] [Abstract][Full Text] [Related]
5. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
[TBL] [Abstract][Full Text] [Related]
6. The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays.
Leunissen TC; Wisman PP; van Holten TC; de Groot PG; Korporaal SJ; Koekman AC; Moll FL; Teraa M; Verhaar MC; de Borst GJ; Urbanus RT; Roest M
Platelets; 2017 Sep; 28(6):567-575. PubMed ID: 27885904
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y
Mitrugno A; Rigg RA; Laschober NB; Ngo ATP; Pang J; Williams CD; Aslan JE; McCarty OJT
Platelets; 2018 Jun; 29(4):383-394. PubMed ID: 28523947
[TBL] [Abstract][Full Text] [Related]
8. Platelet phenotype changes associated with breast cancer and its treatment.
Holmes CE; Levis JE; Schneider DJ; Bambace NM; Sharma D; Lal I; Wood ME; Muss HB
Platelets; 2016 Nov; 27(7):703-711. PubMed ID: 27135253
[TBL] [Abstract][Full Text] [Related]
9. Platelets Express Activated P2Y
Hu L; Chang L; Zhang Y; Zhai L; Zhang S; Qi Z; Yan H; Yan Y; Luo X; Zhang S; Wang Y; Kunapuli SP; Ye H; Ding Z
Circulation; 2017 Aug; 136(9):817-833. PubMed ID: 28637879
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
Castañón E; Soltermann A; López I; Román M; Ecay M; Collantes M; Redrado M; Baraibar I; López-Picazo JM; Rolfo C; Vidal-Vanaclocha F; Raez L; Weder W; Calvo A; Gil-Bazo I
Cancer Lett; 2017 Aug; 402():43-51. PubMed ID: 28549790
[TBL] [Abstract][Full Text] [Related]
11. ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y
Kamiyama M; Shirai T; Tamura S; Suzuki-Inoue K; Ehata S; Takahashi K; Miyazono K; Hayakawa Y; Sato T; Takeda K; Naguro I; Ichijo H
Cell Death Differ; 2017 Dec; 24(12):2066-2076. PubMed ID: 28753204
[TBL] [Abstract][Full Text] [Related]
12. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
13. Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1.
Sippel TR; Johnson AM; Li HY; Hanson D; Nguyen TT; Bullock BL; Poczobutt JM; Kwak JW; Kleczko EK; Weiser-Evans MC; Nemenoff RA
Mol Cancer Res; 2019 Aug; 17(8):1748-1758. PubMed ID: 31088909
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide.
Kirkby NS; Lundberg MH; Chan MV; Vojnovic I; Solomon AB; Emerson M; Mitchell JA; Warner TD
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15782-7. PubMed ID: 24003163
[TBL] [Abstract][Full Text] [Related]
15. P2y12 Receptor Promotes Pressure Overload-Induced Cardiac Remodeling via Platelet-Driven Inflammation in Mice.
Wu L; Zhao F; Dai M; Li H; Chen C; Nie J; Wang P; Wang DW
Hypertension; 2017 Oct; 70(4):759-769. PubMed ID: 28827474
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
17. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
18. Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
Echtler K; Konrad I; Lorenz M; Schneider S; Hofmaier S; Plenagl F; Stark K; Czermak T; Tirniceriu A; Eichhorn M; Walch A; Enders G; Massberg S; Schulz C
PLoS One; 2017; 12(3):e0172788. PubMed ID: 28253287
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointima.
Patil SB; Jackman LE; Francis SE; Judge HM; Nylander S; Storey RF
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2385-91. PubMed ID: 21071697
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation.
Okoshi H; Hakomori S; Nisar M; Zhou QH; Kimura S; Tashiro K; Igarashi Y
Cancer Res; 1991 Nov; 51(22):6019-24. PubMed ID: 1657377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]